3M (1MMM) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Tiotropium | Healthy | Phase I | Completed | Comparison of the Pharmacokinetics of Tiotropium Delivered From Test Inhaler Products With Reference | Oct 02, 2017 | ― |
| Tiotropium | Healthy | Phase I | Completed | Two-period 21 Day Cross-over Study to Compare the Pharmacokinetics of Tiotropium From Two Inhalers | Aug 09, 2017 | ― |
| Tiotropium Pmdi | Healthy | earlyPhase1 | Completed | Comparison of the Pharmacokinetics of Tiotropium Delivered From Test Inhaler Products With A Reference Product | May 15, 2017 | ― |
| Tiotropium | Healthy | Phase I | Completed | Cross-over Study in Volunteers to Compare the Pharmacokinetics of Tiotropium Delivered From Test and Reference Products | Feb 04, 2016 | ― |
| Tiotropium | Healthy | Phase I | Completed | Comparison of the Pharmacokinetics of Tiotropium Delivered From Test Inhaler Products With Two Reference Products | Nov 04, 2015 | ― |
| Mupirocin Calcium Ointment, 2%, 3M Skin And Nasal Antiseptic | Surgical Site Infection | Phase IV | Completed | Prevention of Surgical Site Infections: Effectiveness of Nasal Povidone-Iodine and Nasal Mupirocin | Feb 11, 2011 | ― |
| Avagard, Purell Surgical Scrub | Healthy | Phase IV | Completed | A Two-week Crossover Evaluation of Two Hand Antiseptic Products on Skin Condition in Healthy Human Subjects | Aug 06, 2008 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Tiotropium | Phase I | Healthy | Completed | Comparison of the Pharmacokinetics of Tiotropium Delivered From Test Inhaler Products With Reference | Oct 02, 2017 | ― |
| Tiotropium | Phase I | Healthy | Completed | Two-period 21 Day Cross-over Study to Compare the Pharmacokinetics of Tiotropium From Two Inhalers | Aug 09, 2017 | ― |
| Tiotropium Pmdi | earlyPhase1 | Healthy | Completed | Comparison of the Pharmacokinetics of Tiotropium Delivered From Test Inhaler Products With A Reference Product | May 15, 2017 | ― |
| Tiotropium | Phase I | Healthy | Completed | Cross-over Study in Volunteers to Compare the Pharmacokinetics of Tiotropium Delivered From Test and Reference Products | Feb 04, 2016 | ― |
| Tiotropium | Phase I | Healthy | Completed | Comparison of the Pharmacokinetics of Tiotropium Delivered From Test Inhaler Products With Two Reference Products | Nov 04, 2015 | ― |
| Mupirocin Calcium Ointment, 2%, 3M Skin And Nasal Antiseptic | Phase IV | Surgical Site Infection | Completed | Prevention of Surgical Site Infections: Effectiveness of Nasal Povidone-Iodine and Nasal Mupirocin | Feb 11, 2011 | ― |
| Avagard, Purell Surgical Scrub | Phase IV | Healthy | Completed | A Two-week Crossover Evaluation of Two Hand Antiseptic Products on Skin Condition in Healthy Human Subjects | Aug 06, 2008 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does 3M Company (IT:1MMM) have in its pipeline
3M IT:1MMM is currently developing the following drugs: Tiotropium, Tiotropium Pmdi, Mupirocin Calcium Ointment, 2%, 3M Skin And Nasal Antiseptic, Avagard, Purell Surgical Scrub. These drug candidates are in various stages of clinical development as the company works toward FDA approval.